The first metatarsophalangeal joint is a synovial articulation in the forefoot
comprising the first metatarsal, the hallucal proximal phalanx, and two
sesamoid bones. The two most common non-traumatic diseases affecting the
joint are osteoarthritis and hallux abducto valgus, but rheumatoid arthritis, gout,
and sesamoiditis may also affect the joint. Corticosteroids injection therapy is
used in the treatment of musculoskeletal pathology, in particular via intraarticular delivery to treat the pain associated with joint disease.
Given that the first metatarsophalangeal joint corticosteroid injection is one of
the most commonly performed infiltrations in the foot, this project aims to
identify, synthesise and critique the key concepts for injections in the
management of first metatarsophalangeal joint pathology, to highlight gaps in
our knowledge, to provide answers where possible, and to generate research
questions for future studies.
Whilst providing an overview of injection therapy, local anatomy, joint
pathology, and relevant corticosteroid pharmacology, this thesis has attempted
to provide a through critical appraisal of the existing literature. The initial
scoping review on corticosteroid injections in the management of first
metatarsophalangeal joint pathology, identified the range of available evidence
for all joint pathologies, and produced three themes:
1. Injection therapy outcomes for a given joint pathology,
2. Injection techniques, dosage, and regimen,
3. Injection accuracy and needle placement.
The initial inquiries into these topics involved a systematic review that centred
on the utilisation of corticosteroid injections to address hallux limitus/rigidus.
Despite a limited availability of high-level evidence, this indication was identified
as the most commonly encountered scenario for injection therapy. Data
extracted facilitated the production of a best-practice palpation-guided injection
technique. However, the accuracy of such a technique remained uncertain.
The next schema of work sought to establish the accuracy of palpation-guided
injections using radiopaque contrast media in cadaveric specimens to confirm
the needle placement. The study noted the failure of technique in one of the
six specimens used and extra-articular injectate leakage in another three
specimens. This calls into question the confidence of palpation-guided
techniques for injecting the joint.
Whilst the evidence base suggests that corticosteroid injections are safe shortand mid-term treatment options for soft tissue and joint pathology, the specific
outcomes in the first metatarso-phalangeal joint warrant further study. It needs
to be clarified from the available literature what drug, dose, and at what point in
disease regression is optimal for injection therapy in a given patient. Based on
the findings of this work, future research should include conducting structured
research to establish precise injection therapy protocols for addressing first
metatarsophalangeal joint pathology. The primary emphasis of these
forthcoming studies should be on osteoarthritis of the great toe, given its
prevalence as the most frequently treated condition through injections.
Additionally, high-level studies are also needed to assess the efficacy of
injection therapy in managing other great toe joint pathologies.
Click to expand...